Dr. Reddy’s Laboratories Ltd. and its subsidiaries announced the voluntary recall of its ranitidine medicines that are used to treat heartburn, the U.S. Food and Drug Administration (FDA) said on Wednesday.
The products were found to have N-Nitrosodimethylamine, or NDMA, which is a known carcinogen. According to the Environmental Protection Agency, NDMA is unintentionally introduced into manufacturing through various chemcial reactions, but it is “classified as a B2 (probable human) carcinogen based on the induction of tumors in both rodents and nonrodent mammals exposed” to it.
